30
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Fibrinolytic treatment of intraventricular haemorrhage preceding surgical repair of ruptured aneurysms and arteriovenous malformations

, &
Pages 128-131 | Published online: 06 Jul 2009

  • Findlay JM, Grace MGA, Weir BKA. Treatment of intraventricular haemorrhage with tissue plasminogen activator. Neurosurgery 1993;32:941-7.
  • Findlay JM, Wong JH. Clinical aspects of intraventricular haemorrhage. In:Welch KMA, Caplan LR, Reis DJ, Siesjo BK, eds, Primer on Cerebrovascular Diseases. San Diego: Academic Press; 1997:437-46.
  • Mayfrank L, Lippitz B, Groth M, Bertalanffy H, Gilsbach JM. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage. Acta Neurochir (Wien) 1993;122:32-8.
  • Rohde V, Schaller C, Hassler WE. Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage. J Neurol Neurosurg Psychiatry 1995;58:447-51.
  • Todo T, Usui M, Takakura K. Treatment of severe intraventricular haemorrhage by intraventricular infusion of urokinase. J Neurosurg 1991;74:81-86.
  • Pang D, Sclabassi RJ, Horton JA. Lysis of intraventricular blood clot with urokinase in a canine model: part 3. Effects of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus. Neurosurgery 1986;19:553-572.
  • Mayfrank L, Kissler J, Raoofi R, Delsing P, Weis J, Kuker W, et al. Ventricular dilatation in experimental intraventricular haemorrhage. Characterization of CSF dynamics and the effects of fibrinolytic treatment. Stroke 1997;28:141-8.
  • Mayfrank L, Delsing P, Kissler J, Raoofi R, Weis J, Kuker W, et al. The effects of tissue-type plasminogen activator (tPA) on clot lysis and ventricular dilation in a new experimental model of intraventricular haemorrhage. In: Boker KD, ed., Therapeutic Concepts in Spontaneous Intracerebral Haemorrhage. Zulpich: Biermann, 1997;31-6.
  • Seifert V, Stolke D, Zimmermann M, Feldges A. Prevention of delayed ischemic deficits after aneurysmal subarachnoid haemorrhage by intrathecal bolus injection of tissue plasminogen activator (rTPA). A prospective study. Acta Neurochir (Wien) 1994; 128:137-43.
  • Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968;28:4-20.
  • Teasdale G, Jennet B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;ii:81-4.
  • LeRoux PD, Haglund MM, Newell DW, Grady SM, Winn HR. Intraventricular haemorrhage in blunt head trauma: an analysis of 43 cases. Neurosurgery 1992;31:678-85.
  • Jennet B, Bond M. Assessment of outcome after severe brain damage -- a practical scale. Lancet 1975;ii:480-4.
  • Mohr G, Ferguson G, Khan M, Malloy D, Watts R, Benoit B, et al. Intraventricular haemorrhage from ruptured aneurysm. J Neurosurg 1983;58:482-7.
  • Donauer E, Reif J, Al-Khalaf B, Mengedroht EF, Faubert C. Intraventricular haemorrhage caused by aneurysms and angiomas. Acta Neurochir (Wien) 1993;122:23-31.
  • Shapiro AS, Campbell RL, Scully T. Haemorrhagic dilation of the fourth ventricle: an ominous predictor. J Neurosurg 1994;80:805-9.
  • Schwarz S, Schwab S, Steiner HH, Hacke W. Secondary haemorrhage after intraventricular fibrinolysis: a cautionary report: report of two cases. Neurosurgery 1998;42:659-63.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.